Antimicrobials & SSTIs Flashcards

1
Q

Therapeutic balance of ID
Maximize ____ and minimize ___

A

Maximize bacterial killing, safety, and efficacy
Minimize toxicity & resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ecological adverse effects of antibiotic therapy, specifically selection of drug-resistant organisms and the unwanted development of colonization or infection with MDR organisms

A

collateral damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

collateral damage risks associated with cephalosporin

A

-subsequent infections with VRE
-extended spectrum B-lactamase producing K. pneumoniae
-B-lactam resistant Acinetobacter species
-C. diff

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

the lowest concentration of an antibiotic that completely inhibits the growth of a microorganism in vitro

A

MIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

the lowest concentration of the antibiotic which results in a 99.9% reduction in colony forming units in a given time

A

MBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

species that is
-gram + cocci
-clusters (catalase -)
-coagulase +

A

S. aureus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

species that is
-gram + cocci
-clusters (catalase -)
-coagulase -

A

S. epidermidis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

species that is
-gram + cocci
-pairs (catalase +)
-alpha

A

S. pneumoniae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

species that is
-gram + cocci
-chains
-beta

A

Group A strep (S. pyogenes)
Group B strep (S. agalactiae)
Group C, G, F strep

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

species that is
-gram + cocci
-chains
-gamma

A

enterococcus species
E. faecalis
E. faecium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

drugs for MSSA (S. aureus, 50%)

A

nafcillin, oxacillin, dicloxacillin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

drugs for MRSA (S. aureus, 50%)

A

vancomycin, linezolid, daptomycin, Bactrim, clindamycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

drugs for MSSE (S. epidermidis, 20%)

A

nafcillin, oxacillin, dicloxacillin (same as MSSA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

drugs for MRSA (S. epidermidis, 80%)

A

vancomycin, linezolid, daptomycin, Bactrim, clindamycin (same as MRSA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

drugs for PCN (S) S. pneumoniae (90%)

A

penicillin G/V, nafcillin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

drugs for PCN (R) S. pneumoniae (10%)

A

vancomycin, Bactrim

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

drugs for PCN (S) streptococcus

A

penicillin G/V, nafcillin (same as S. pneumoniae)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

drugs for PCN (R) streptococcus

A

vancomycin, Bactrim (same as S. pneumoniae)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

drug options for enterococcus species (E. faecalis, E. faecium)

A
  1. ampicillin +/- gentamicin
  2. vancomycin +/- gentamicin
  3. linezolid, daptomycin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

drug for gram positive aerobe cocci

A

clindamycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

drug for gram positive aerobe bacilli

A

metronidazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

gram - cocci PEK species

A

Proteus mirabilus
Escherichia coli
Klebsiella pneumoniae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

gram - cocci HEM species

A

Haemophilus influenzae
Enterobacteriaceae (salmonella, shigella)
Monexella catanthalis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

gram - cocci SPACE species

A

Serratia marcesens
Pseudomonas aeruginosa
Acinetobacter baumannii
Citrobacter
Enterobacter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
cephalosporins that cover PEK bacteria
cefazolin, cephalexin, cefadroxil
26
cephalosporins that cover PEKHEM bacteria
1) cefuroxime, cefaclor 2) cephamycins, cefoxitin, cefotetan cefmetazole
27
cephalosporins that cover PEKHEM S_ACE bacteria
1)Ceftriaxone, cefpodoxime proxetil anti-pseudomonal: ceftazidime, cefoperazone 2) cefepime 3) ceftaroline
28
which cephalosporin is best for SPACE organisms
ceftazidime
29
which drugs are used for pseudomonas
combinations including: -piperacillin/tazobactam -carbapenems (meropenem, imipenem) -ceftazidime
30
PKPD indices for antibiotic effect
Cmax:MIC %T>MIC AUC:MIC
31
which drugs follow: -time dependent killing -min/mod persistent effects
penicillins cephalosporins carbapenems macrolides oxazolidinones
32
what is the PKPD index that influences time dependent killing and min/mod persistent effects
%T/MIC
33
which drugs follow: -concentration dependence -prolonged persistent effects
aminoglycosides quinolones
34
which PKPD indices influence concentration dependence and prolonged persistent effects
Cmax:MIC AUC:MIC
35
which drugs follow: -time dependent killing -prolonged persistent effects
vancomycin azithromycin tetracycline
36
which PKPD index influences time dependent killing and prolonged persistent effects
AUC:MIC
37
how do pH changes alter PK
altered drug ionization
38
how do changes in organ blood flow alter PK
altered drug CL
39
how to fluid shifts alter PK
altered Vd
40
how do changes in albumin alter PK
changes in free drug
41
hydrophilic antimicrobials
aminoglycosides beta lactams (carbapenems, cephalosporins, penicillins) glycopeptides lipopeptides
42
lipophilic antimicrobials
fluoroquinolones glyclcycline ketolides lincosamides macrolides metronidazole streptogramins tetracyclines
43
how do hydrophilic drugs alter PK
tissue distribution limited to extracellular space inc LD and inc/dec MD
44
how do lipophilic drugs alter PK
tissue distribution with intracellular accumulation no change to LD or MD
45
how does infection in blood alter PK
inc Vd and CL
46
how does infection in lung alter PK
impaired permeability
47
how does infection in soft tissue alter PK
variable by composition
48
how does infection in bone alter PK
impaired permeability
49
how does infection in the CNS alter PK
impaired permeability
50
fluid shifts in sepsis do what to CL, Vd, and drug conc?
can lead to high or low Vd, impaired or augmented CL, and too high or too low drug conc
51
antibiotics that do not need renal dose adjustment
ceftriaxone clindamycin oxacillin moxifloxacin metronidazole azithromycin nafcillin doxycycline erythromycin dalfopristin/quinupristin tigecycline linezolid
52
decisions for which drug to use should be made based off
S, R, or I.... NOT the number
53
greater outcomes were seen for fluoroquinolones with an AUC:MIC
>125
54
target AUC24,ss:MIC for vancomycin
>400 ng*h/L
55
types of purulent infections
cutenous abscess, furuncle, carbuncle
56
presentation of purulent infection
painful, fluctuant red nodules, topped with pustule, rim of erythematous swelling
57
common microbial cause of purulent infection
S. aureus
58
General treatment approach for purulent infections
must do I&D antibiotics if there are systemic signs of infection, do not respond to I&D, etc (SIRS criteria, mod to sev)
59
IV drugs for purulent MRSA infections (empiric)
vancomycin, daptomycin, ceftaroline, dalbavancin/oritavancin
60
oral drugs for purulent MRSA infections (empiric)
Bactrim, doxycycline, linezolid
61
IV drugs for purulent MSSA infections (de-escalate)
ampicillin/sulbactam, nafcillin/oxacillin, cefazolin
62
oral drugs for purulent MSSA infections (de-escalate)
amox/clav, dicloxacillin, cephalexin, clindamycin
63
duration of therapy purulent infection
5-10 days following I&D
64
types of nonpurulent infection
cellulutis, erysipelas
65
presentation of nonpurulent infection
red, warm, swollen, painful
66
common microbial cause of nonpurulent infection
streptococcus species, some S. aureus
67
general treatment approach for nonpurulent infection
antibiotics oral for mild oral or IV for moderate IV for severe
68
oral drugs for nonpurulent infection (strep)
penicillin VK, amoxicillin, amox/clav, cephalexin, clindamycin (allergy)
69
IV drugs for nonpurulent infection (strep)
penicillin G, cefazolin, ceftriaxone, clindamycin (allergy) severe allergy- clindamycin, vancomycin, linezolid, daptomycin
70
treatment duration for nonpurulent infection
5 days if mild, 10-14 if mod-sev
71
deep infection involving the superficial fascia comprising all tissue between the skin and muscle
necrotizing fasciitis
72
microbial causes of necrotizing fasciitis
mono: S. pyogenes, S. aureus, Clostridium poly: mixed aerobic/anaerobic
73
general treatment approach for necrotizing fasciitis
surgery broad spectrum antibiotics started then de-escalated
74
drug for necrotizing fasciitis that covers MRSA
vancomycin +
75
drug for necrotizing fasciitis that covers gram -
pip-tazo, carbapenems, cefepime +, ciprofloxacin +
76
drug for necrotizing fasciitis that covers anaerobes
pip-tazo, carbapenems, metronidazole, clindamycin
77
microbial species common in infected animal bites
pasturella species
78
oral and IV drugs for bite wounds
IV- ampicillin/sulbactam Oral- amox/clav Alt- 2nd/3rd gen cephalosporins + metronidazole, levofloxacin + metronidazole
79
presentation for DFIs
redness, warmth, swelling, tenderness, pain, purulent drainage (from ulcer) (need 2 or more to be infected)
80
microbes that cause DFIs
gram + cocci: staphylococcus and streptococcus gram - bacilli: pseudomonas anaerobes: may be seen in mod-sev
81
mild oral therapy for DFI
MSSA/strep- cephalexin, amox/clav, clindamycin MRSA- bactrim, doxycycline
82
mod-severe IV therapy for DFI
MSSA/strep/gram neg/anaerobes- amp/sulbact, cefoxitin, ceftriaxone + metro, cipro + clindamyc, moxifloxacin, ertapenem MRSA- vancomycin, linezolid, daptomycin pseudomonas- pip/tazo, cefepime
83